CYCLOBENZAPRINE

CYCLOBENZAPRINE was reported 50569 times

CYCLOBENZAPRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEDATION COMPLICATION 550 0.2153
1 TEMPERATURE REGULATION DISORDER 475 0.2130
2 VASCULAR MALFORMATION 43 0.2048
3 PULMONARY MALFORMATION 65 0.1852
4 PARANASAL CYST 43 0.1770
5 HYPOCHOLESTEROLAEMIA 56 0.1586
6 OVERLAP SYNDROME 95 0.1357
7 CREATININE RENAL CLEARANCE DECREASED 541 0.1350
8 MULTIPLE DRUG THERAPY 90 0.1194
9 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 121 0.1139
10 LUNG CYST 44 0.1120
11 NEPHROGENIC ANAEMIA 439 0.0947
12 HYPERPARATHYROIDISM SECONDARY 235 0.0937
13 FOOD ALLERGY 637 0.0824
14 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 42 0.0803
15 CREATININE RENAL CLEARANCE INCREASED 60 0.0802
16 REBOUND ACID HYPERSECRETION 241 0.0796
17 INFUSION SITE REACTION 236 0.0789
18 LUPUS VULGARIS 95 0.0754
19 FACET JOINT SYNDROME 240 0.0736
20 POST-TRAUMATIC NECK SYNDROME 58 0.0717
21 PERIPHERAL VENOUS DISEASE 289 0.0707
22 BURSITIS 818 0.0674
23 BLEPHAROSPASM 418 0.0663
24 SOFT TISSUE INJURY 47 0.0621
25 BONE DEMINERALISATION 57 0.0538
26 FOETAL DEATH 279 0.0537
27 BLOOD CALCIUM DECREASED 583 0.0518
28 MASTOIDITIS 50 0.0510
29 COELIAC DISEASE 480 0.0489
30 DISLOCATION OF VERTEBRA 109 0.0477
31 IMMUNODEFICIENCY 707 0.0474
32 RETINITIS 77 0.0445
33 ONYCHOMADESIS 183 0.0436
34 STERNAL FRACTURE 52 0.0421
35 BREAST CANCER STAGE III 268 0.0413
36 RHEUMATIC FEVER 184 0.0412
37 END STAGE RENAL DISEASE 725 0.0397
38 ORTHOSTATIC HYPOTENSION 688 0.0395
39 X-RAY ABNORMAL 70 0.0391
40 BRONCHIAL HYPERREACTIVITY 47 0.0391
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 267 0.0372
42 CHRONIC KIDNEY DISEASE 2750 0.0362
43 BACK INJURY 393 0.0361
44 BLOOD PRESSURE DIASTOLIC ABNORMAL 91 0.0357
45 DEEP VEIN THROMBOSIS POSTOPERATIVE 67 0.0334
46 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 67 0.0323
47 HYPERCHOLESTEROLAEMIA 310 0.0321
48 PULMONARY FUNCTION TEST ABNORMAL 50 0.0321
49 DISTRIBUTIVE SHOCK 71 0.0313
50 ESSENTIAL HYPERTENSION 57 0.0311
51 DUODENAL ULCER PERFORATION 230 0.0309
52 SUSPECTED SUICIDE 143 0.0305
53 FOLLICULITIS 307 0.0292
54 SEDATION 757 0.0289
55 PORPHYRIA ACUTE 41 0.0286
56 PRESCRIBED OVERDOSE 544 0.0281
57 NASAL DISCHARGE DISCOLOURATION 38 0.0275
58 MUSCLE INJURY 228 0.0275
59 INFUSION SITE DISCHARGE 48 0.0274
60 CERVICAL SPINAL STENOSIS 46 0.0267
61 FIBROMYALGIA 649 0.0267
62 SWOLLEN JOINT COUNT INCREASED 84 0.0263
63 PRE-EXISTING CONDITION IMPROVED 163 0.0261
64 HELICOBACTER INFECTION 260 0.0253
65 WOUND INFECTION 275 0.0251
66 JOINT RANGE OF MOTION DECREASED 326 0.0243
67 LIVE BIRTH 202 0.0241
68 COMPLETED SUICIDE 2001 0.0240
69 BLOOD PRESSURE SYSTOLIC ABNORMAL 59 0.0238
70 SACROILIITIS 45 0.0238
71 EXOSTOSIS 216 0.0236
72 CONTRAINDICATED PRODUCT ADMINISTERED 703 0.0232
73 LIBIDO INCREASED 47 0.0232
74 TASTE DISORDER 467 0.0230
75 PERSONALITY DISORDER 59 0.0225
76 FEAR OF DISEASE 40 0.0225
77 BONE EROSION 79 0.0223
78 INTERVERTEBRAL DISC DEGENERATION 206 0.0222
79 IMPAIRED GASTRIC EMPTYING 300 0.0220
80 RENAL FUNCTION TEST ABNORMAL 99 0.0213
81 LIP DRY 191 0.0210
82 NAIL DISORDER 183 0.0209
83 HOSTILITY 52 0.0204
84 ECONOMIC PROBLEM 310 0.0204
85 RENAL INJURY 605 0.0203
86 DEPRESSED LEVEL OF CONSCIOUSNESS 795 0.0201
87 OBESITY 318 0.0199
88 UPPER RESPIRATORY TRACT INFECTION 897 0.0194
89 IRRITABLE BOWEL SYNDROME 413 0.0192
90 PEMPHIGUS 235 0.0188
91 RED BLOOD CELL SEDIMENTATION RATE INCREASED 207 0.0187
92 INFUSION SITE PRURITUS 59 0.0187
93 SYNOVITIS 334 0.0185
94 OTITIS MEDIA 61 0.0184
95 ANHEDONIA 485 0.0184
96 ISCHAEMIC CARDIOMYOPATHY 55 0.0179
97 INFUSION SITE HAEMORRHAGE 59 0.0179
98 COGNITIVE DISORDER 830 0.0178
99 SPINAL OSTEOARTHRITIS 155 0.0176
100 PRODUCT ADMINISTRATION INTERRUPTED 138 0.0176
101 HAND DEFORMITY 230 0.0175
102 RESPIRATORY DEPRESSION 211 0.0172
103 INFUSION SITE BRUISING 37 0.0171
104 VAGINAL INFECTION 79 0.0168
105 DRUG TOLERANCE 84 0.0166
106 GRIP STRENGTH DECREASED 146 0.0166
107 MATERNAL EXPOSURE DURING BREAST FEEDING 66 0.0163
108 NECK INJURY 47 0.0160
109 OSTEOARTHRITIS 676 0.0159
110 HEPATIC ENZYME INCREASED 1082 0.0159
111 GLOSSODYNIA 354 0.0158
112 CATHETER SITE PAIN 41 0.0158
113 POST-TRAUMATIC STRESS DISORDER 105 0.0157
114 RHEUMATOID FACTOR POSITIVE 90 0.0156
115 EXPOSURE VIA BREAST MILK 62 0.0156
116 SCIATICA 248 0.0155
117 INFUSION RELATED REACTION 1015 0.0153
118 CLONUS 41 0.0150
119 MENISCUS INJURY 92 0.0149
120 INTERVERTEBRAL DISC PROTRUSION 327 0.0149
121 SLEEP APNOEA SYNDROME 285 0.0149
122 FINE MOTOR SKILL DYSFUNCTION 43 0.0148
123 CONCUSSION 115 0.0148
124 RADICULOPATHY 39 0.0148
125 GASTROOESOPHAGEAL REFLUX DISEASE 1190 0.0148
126 PERICARDITIS 248 0.0147
127 RESPIRATORY ARREST 406 0.0147
128 EXPOSURE VIA INGESTION 37 0.0147
129 TUBULOINTERSTITIAL NEPHRITIS 272 0.0145
130 OSTEOPOROSIS 594 0.0144
131 OSTEOPENIA 219 0.0144
132 RENAL TUBULAR NECROSIS 141 0.0144
133 PSORIATIC ARTHROPATHY 578 0.0142
134 MOBILITY DECREASED 1022 0.0142
135 ONYCHOMYCOSIS 62 0.0141
136 FLUID RETENTION 715 0.0140
137 CHOLECYSTITIS CHRONIC 94 0.0140
138 TOXICITY TO VARIOUS AGENTS 2352 0.0139
139 PRE-ECLAMPSIA 66 0.0139
140 RASH ERYTHEMATOUS 658 0.0137
141 RENAL FAILURE 1824 0.0137
142 BREATH SOUNDS ABNORMAL 67 0.0136
143 ANKYLOSING SPONDYLITIS 179 0.0136
144 AUTOIMMUNE DISORDER 132 0.0135
145 BACK DISORDER 218 0.0134
146 FOOT FRACTURE 254 0.0134
147 NECK PAIN 747 0.0134
148 SEASONAL ALLERGY 188 0.0133
149 DRUG ABUSE 1104 0.0132
150 ROTATOR CUFF SYNDROME 169 0.0131
151 INFUSION SITE SWELLING 82 0.0130
152 FIBULA FRACTURE 37 0.0128
153 PUSTULAR PSORIASIS 44 0.0128
154 C-REACTIVE PROTEIN ABNORMAL 82 0.0128
155 BLOOD PRESSURE DIASTOLIC INCREASED 59 0.0128
156 IMPAIRED HEALING 418 0.0127
157 SPINAL STENOSIS 52 0.0126
158 RHEUMATOID ARTHRITIS 1429 0.0126
159 SPINAL FUSION SURGERY 51 0.0126
160 EPILEPSY 382 0.0125
161 ACUTE KIDNEY INJURY 1906 0.0124
162 SPINAL OPERATION 153 0.0124
163 WOUND 347 0.0124
164 VITAMIN D DEFICIENCY 121 0.0124
165 TYPE 2 DIABETES MELLITUS 411 0.0122
166 INTERVERTEBRAL DISC DISORDER 52 0.0122
167 TOOTH ABSCESS 124 0.0122
168 CARDIO-RESPIRATORY ARREST 505 0.0121
169 GAIT INABILITY 398 0.0119
170 BALANCE DISORDER 1025 0.0118
171 LIVER FUNCTION TEST INCREASED 252 0.0117
172 EAR PAIN 224 0.0115
173 MIGRAINE 1090 0.0114
174 NIGHT SWEATS 366 0.0113
175 FINGER DEFORMITY 55 0.0113
176 TENDERNESS 118 0.0113
177 MUSCLE STRAIN 97 0.0112
178 ASTHMA 1260 0.0111
179 POISONING 140 0.0111
180 EXPOSURE DURING PREGNANCY 690 0.0111
181 BLADDER DISORDER 110 0.0111
182 NEPHROPATHY 103 0.0110
183 LIGAMENT SPRAIN 109 0.0110
184 ENCEPHALOPATHY 270 0.0110
185 MACULOPATHY 39 0.0110
186 RIB FRACTURE 226 0.0110
187 DRUG INTOLERANCE 1060 0.0110
188 THYROID MASS 42 0.0109
189 PSYCHOLOGICAL TRAUMA 94 0.0109
190 PARANASAL SINUS DISCOMFORT 41 0.0108
191 FOOT DEFORMITY 120 0.0108
192 LOWER LIMB FRACTURE 207 0.0108
193 HYPERLIPIDAEMIA 128 0.0107
194 SOMNAMBULISM 70 0.0107
195 WALKING AID USER 70 0.0106
196 MULTIPLE ALLERGIES 83 0.0106
197 SPINAL DISORDER 100 0.0105
198 RHINITIS ALLERGIC 47 0.0105
199 NERVE COMPRESSION 97 0.0105
200 DIABETIC NEUROPATHY 52 0.0105
201 ULCER HAEMORRHAGE 71 0.0105
202 TONGUE OEDEMA 40 0.0105
203 INFUSION SITE PAIN 135 0.0105
204 COMPRESSION FRACTURE 56 0.0104
205 INFUSION SITE ERYTHEMA 88 0.0104
206 SKIN ABRASION 49 0.0104
207 HYPERAESTHESIA 85 0.0103
208 MUSCULOSKELETAL PAIN 537 0.0102
209 JOINT SWELLING 1236 0.0102
210 SCOLIOSIS 63 0.0102
211 TOOTH FRACTURE 112 0.0101
212 IMPAIRED QUALITY OF LIFE 146 0.0101
213 POOR VENOUS ACCESS 105 0.0101
214 SNORING 38 0.0100
215 CONSTIPATION 2188 0.0100
216 ARTHROPATHY 556 0.0100
217 WEIGHT FLUCTUATION 104 0.0099
218 BLOOD PRESSURE DIASTOLIC DECREASED 73 0.0099
219 BLOOD CHOLESTEROL INCREASED 461 0.0099
220 DECREASED IMMUNE RESPONSIVENESS 97 0.0099
221 HAND FRACTURE 70 0.0099
222 BREAST CANCER STAGE II 82 0.0098
223 CARPAL TUNNEL SYNDROME 138 0.0098
224 SINUSITIS 1000 0.0097
225 ANKLE FRACTURE 151 0.0097
226 INFLAMMATION 503 0.0097
227 MAJOR DEPRESSION 71 0.0097
228 MULTIPLE DRUG OVERDOSE 48 0.0097
229 SYSTEMIC LUPUS ERYTHEMATOSUS 343 0.0097
230 BODY TEMPERATURE DECREASED 95 0.0096
231 TOOTH INFECTION 127 0.0096
232 BLOOD PRESSURE SYSTOLIC INCREASED 187 0.0096
233 ARTHROPOD BITE 71 0.0096
234 BIPOLAR DISORDER 104 0.0096
235 AUTOIMMUNE THYROIDITIS 36 0.0095
236 LIGAMENT RUPTURE 42 0.0095
237 SEROTONIN SYNDROME 182 0.0095
238 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 48 0.0094
239 BRONCHITIS 693 0.0094
240 DRY MOUTH 757 0.0093
241 BACK PAIN 2166 0.0093
242 RENAL CYST 74 0.0093
243 MULTIPLE FRACTURES 153 0.0093
244 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 159 0.0093
245 BLOOD PRESSURE FLUCTUATION 222 0.0092
246 SPINAL PAIN 108 0.0092
247 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 156 0.0092
248 JOINT DISLOCATION 97 0.0092
249 SHOULDER OPERATION 39 0.0091
250 GASTROENTERITIS VIRAL 164 0.0091
251 THERAPEUTIC PRODUCT EFFECT DECREASED 403 0.0090
252 DENTAL CARIES 99 0.0089
253 DIVERTICULUM 63 0.0089
254 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 425 0.0088
255 LUNG DISORDER 433 0.0088
256 LARGE INTESTINE POLYP 61 0.0088
257 ABDOMINAL HERNIA 40 0.0088
258 JOINT INJURY 187 0.0087
259 HYPERHIDROSIS 1127 0.0087
260 TIBIA FRACTURE 41 0.0087
261 C-REACTIVE PROTEIN INCREASED 317 0.0087
262 SPINAL COMPRESSION FRACTURE 72 0.0087
263 TREATMENT FAILURE 720 0.0087
264 CARDIOMYOPATHY 128 0.0087
265 NORMAL NEWBORN 47 0.0086
266 BONE DISORDER 156 0.0086
267 INJURY 601 0.0085
268 NERVE INJURY 95 0.0085
269 LUMBAR VERTEBRAL FRACTURE 39 0.0085
270 LIMB INJURY 231 0.0085
271 BLISTER 476 0.0085
272 GLUCOSE TOLERANCE IMPAIRED 50 0.0084
273 PAIN 5189 0.0084
274 HIATUS HERNIA 109 0.0084
275 JOINT EFFUSION 58 0.0084
276 LUPUS-LIKE SYNDROME 76 0.0084
277 WRIST FRACTURE 100 0.0083
278 TEMPERATURE INTOLERANCE 86 0.0083
279 ORAL DISORDER 61 0.0083
280 HYPERVOLAEMIA 41 0.0083
281 HYPOAESTHESIA 1229 0.0082
282 CARDIOMEGALY 101 0.0082
283 HYSTERECTOMY 71 0.0082
284 MIDDLE INSOMNIA 153 0.0082
285 POLYARTHRITIS 43 0.0081
286 VASCULAR DEVICE INFECTION 37 0.0081
287 JOINT STIFFNESS 213 0.0081
288 EAR INFECTION 216 0.0081
289 LYMPHOEDEMA 56 0.0081
290 MASS 113 0.0081
291 LIVER INJURY 198 0.0081
292 SPINAL COLUMN STENOSIS 38 0.0080
293 ROAD TRAFFIC ACCIDENT 335 0.0080
294 INTENTIONAL PRODUCT MISUSE 701 0.0080
295 OVERWEIGHT 43 0.0080
296 INSURANCE ISSUE 121 0.0079
297 QUALITY OF LIFE DECREASED 106 0.0079
298 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 51 0.0078
299 ASPIRATION 86 0.0078
300 MUSCLE SPASMS 1440 0.0078
301 ONYCHOCLASIS 54 0.0078
302 SINUS DISORDER 155 0.0078
303 INTENTIONAL PRODUCT USE ISSUE 683 0.0078
304 PERIPHERAL SWELLING 1200 0.0078
305 POOR QUALITY SLEEP 167 0.0077
306 DEPRESSION 1758 0.0077
307 ARTERIOSCLEROSIS CORONARY ARTERY 51 0.0077
308 MEMORY IMPAIRMENT 1057 0.0077
309 PATHOLOGICAL FRACTURE 39 0.0077
310 RASH VESICULAR 37 0.0076
311 DERMATITIS CONTACT 87 0.0076
312 PHLEBITIS 39 0.0076
313 HEPATIC CIRRHOSIS 143 0.0076
314 BRUXISM 41 0.0076
315 UNRESPONSIVE TO STIMULI 196 0.0076
316 HYPERTENSION 1607 0.0076
317 SLEEP DISORDER 535 0.0076
318 RHINITIS 61 0.0076
319 GALLBLADDER DISORDER 135 0.0076
320 MUSCULOSKELETAL CHEST PAIN 117 0.0076
321 ATELECTASIS 73 0.0075
322 CHOLECYSTITIS 90 0.0075
323 MUSCULOSKELETAL DISCOMFORT 130 0.0075
324 STOMATITIS 458 0.0075
325 SINUS CONGESTION 102 0.0075
326 HAIR DISORDER 62 0.0075
327 RESTLESS LEGS SYNDROME 136 0.0075
328 HEPATIC STEATOSIS 139 0.0075
329 BLOOD IRON DECREASED 88 0.0074
330 POSTOPERATIVE WOUND INFECTION 50 0.0074
331 FALL 2463 0.0074
332 FACIAL PAIN 66 0.0074
333 INFUSION SITE EXTRAVASATION 46 0.0074
334 SPINAL FRACTURE 148 0.0074
335 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
336 PULMONARY FIBROSIS 141 0.0073
337 MUSCULOSKELETAL STIFFNESS 643 0.0073
338 DECREASED ACTIVITY 79 0.0073
339 RESPIRATORY TRACT CONGESTION 116 0.0073
340 SKIN ATROPHY 42 0.0073
341 NEURALGIA 177 0.0073
342 SINUS HEADACHE 43 0.0072
343 STRESS FRACTURE 39 0.0072
344 WHEEZING 428 0.0072
345 PHARYNGITIS STREPTOCOCCAL 78 0.0072
346 NODULE 94 0.0072
347 HEREDITARY ANGIOEDEMA 77 0.0072
348 SKIN LACERATION 78 0.0072
349 ARTHRITIS 564 0.0072
350 HYPOTENSION 1438 0.0072
351 BONE DENSITY DECREASED 224 0.0071
352 HYPOTHYROIDISM 228 0.0071
353 ANXIETY 2018 0.0071
354 CHOLECYSTECTOMY 81 0.0071
355 RETCHING 151 0.0071
356 CONTUSION 678 0.0070
357 HEART RATE ABNORMAL 39 0.0070
358 MALNUTRITION 78 0.0070
359 HAEMORRHOIDS 135 0.0069
360 UPPER-AIRWAY COUGH SYNDROME 57 0.0069
361 KNEE OPERATION 68 0.0069
362 SWELLING 641 0.0068
363 INTENTIONAL DOSE OMISSION 195 0.0068
364 PRODUCTIVE COUGH 326 0.0068
365 SCRATCH 72 0.0068
366 PELVIC FRACTURE 53 0.0068
367 CYSTITIS 216 0.0068
368 DISABILITY 134 0.0068
369 DYSPEPSIA 666 0.0068
370 RESPIRATORY TRACT INFECTION 176 0.0068
371 INCREASED TENDENCY TO BRUISE 62 0.0067
372 CHOLELITHIASIS 220 0.0067
373 BEDRIDDEN 88 0.0067
374 ARTERIOSCLEROSIS 63 0.0067
375 PRODUCT DISTRIBUTION ISSUE 62 0.0067
376 MULTIPLE INJURIES 42 0.0067
377 HYPERSENSITIVITY 1238 0.0067
378 VITAMIN D DECREASED 57 0.0067
379 HIP SURGERY 36 0.0066
380 INTENTIONAL DRUG MISUSE 139 0.0066
381 POST PROCEDURAL INFECTION 54 0.0066
382 DECREASED INTEREST 39 0.0066
383 OVARIAN CYST 66 0.0066
384 HAIR TEXTURE ABNORMAL 88 0.0066
385 CARDIAC ARREST 543 0.0066
386 DIVERTICULITIS 182 0.0066
387 ANAL INCONTINENCE 59 0.0066
388 EYE INFECTION 74 0.0065
389 ATRIAL FLUTTER 52 0.0065
390 URINARY INCONTINENCE 192 0.0065
391 SINUS TACHYCARDIA 92 0.0065
392 SURGERY 378 0.0064
393 OXYGEN SATURATION DECREASED 362 0.0064
394 PRODUCT DOSE OMISSION IN ERROR 182 0.0064
395 KIDNEY INFECTION 126 0.0064
396 BLOOD POTASSIUM DECREASED 193 0.0064
397 SKIN LESION 176 0.0064
398 DISCOMFORT 391 0.0064
399 HYPOKINESIA 93 0.0064
400 ACUTE RESPIRATORY FAILURE 123 0.0064
401 SUPRAVENTRICULAR TACHYCARDIA 61 0.0064
402 LOCALISED INFECTION 154 0.0064
403 PARAESTHESIA 1001 0.0064
404 MITRAL VALVE INCOMPETENCE 72 0.0064
405 OSTEOMYELITIS 115 0.0063
406 PRODUCT LABEL CONFUSION 37 0.0063
407 NEPHROLITHIASIS 291 0.0063
408 INFECTION 918 0.0063
409 MUSCULAR WEAKNESS 719 0.0063
410 FEELING OF BODY TEMPERATURE CHANGE 37 0.0063
411 TRICUSPID VALVE INCOMPETENCE 50 0.0063
412 CYST 78 0.0063
413 PERIPHERAL COLDNESS 86 0.0063
414 NASOPHARYNGITIS 1149 0.0062
415 CEREBRAL DISORDER 46 0.0062
416 DYSPNOEA EXERTIONAL 234 0.0062
417 DRUG SCREEN POSITIVE 49 0.0062
418 HAIR COLOUR CHANGES 77 0.0062
419 BRAIN INJURY 62 0.0062
420 APHONIA 86 0.0062
421 PSORIASIS 804 0.0061
422 EMOTIONAL DISTRESS 743 0.0061
423 BRAIN FOG 96 0.0061
424 ILLNESS 631 0.0061
425 SPUTUM DISCOLOURED 58 0.0061
426 ABDOMINAL PAIN UPPER 1258 0.0061
427 PULMONARY MASS 91 0.0061
428 ARTHRALGIA 2535 0.0061
429 BODY TEMPERATURE INCREASED 124 0.0061
430 LIMB DISCOMFORT 188 0.0061
431 MUSCLE TWITCHING 140 0.0061
432 THERMAL BURN 43 0.0061
433 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 315 0.0060
434 FUNGAL INFECTION 201 0.0060
435 DELIRIUM 209 0.0060
436 PAIN IN EXTREMITY 1774 0.0060
437 DEEP VEIN THROMBOSIS 391 0.0060
438 BODY HEIGHT DECREASED 64 0.0060
439 KNEE ARTHROPLASTY 126 0.0060
440 TOOTH LOSS 124 0.0060
441 SENSORY LOSS 48 0.0060
442 FREQUENT BOWEL MOVEMENTS 160 0.0059
443 PRESCRIBED UNDERDOSE 118 0.0059
444 GASTROINTESTINAL INFECTION 53 0.0059
445 OROPHARYNGEAL PAIN 547 0.0059
446 DEFORMITY 55 0.0059
447 APPETITE DISORDER 39 0.0059
448 BLOOD PRESSURE INCREASED 898 0.0059
449 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51 0.0059
450 URINARY TRACT INFECTION 999 0.0059
451 CELLULITIS 295 0.0058
452 EMPHYSEMA 59 0.0058
453 TONGUE DISORDER 42 0.0058
454 POLYP 38 0.0058
455 TOOTH DISORDER 129 0.0058
456 MENTAL STATUS CHANGES 161 0.0058
457 HYPERSOMNIA 166 0.0058
458 POST PROCEDURAL COMPLICATION 111 0.0058
459 HEADACHE 3623 0.0058
460 MATERNAL EXPOSURE DURING PREGNANCY 515 0.0058
461 SUBSTANCE ABUSE 47 0.0058
462 PYELONEPHRITIS 50 0.0058
463 STAPHYLOCOCCAL INFECTION 190 0.0058
464 HEART RATE DECREASED 202 0.0057
465 HIP ARTHROPLASTY 88 0.0057
466 ORAL HERPES 112 0.0057
467 HEAD INJURY 181 0.0057
468 FEELING HOT 349 0.0057
469 BLOOD PRESSURE ABNORMAL 113 0.0057
470 OBSTRUCTIVE AIRWAYS DISORDER 63 0.0057
471 FLANK PAIN 53 0.0056
472 BONE PAIN 331 0.0056
473 PRODUCT USE ISSUE 1061 0.0056
474 WEIGHT INCREASED 1263 0.0056
475 HYPERTHERMIA 43 0.0056
476 SKIN INFECTION 63 0.0056
477 INFLUENZA 626 0.0056
478 PULMONARY CONGESTION 74 0.0056
479 GASTRITIS 147 0.0056
480 LOWER RESPIRATORY TRACT INFECTION 254 0.0056
481 NIGHTMARE 193 0.0056
482 ILEUS 69 0.0055
483 PAIN IN JAW 157 0.0055
484 AMNESIA 360 0.0055
485 UPPER LIMB FRACTURE 110 0.0055
486 HEPATOMEGALY 54 0.0055
487 ORAL PAIN 123 0.0055
488 CORONARY ARTERY DISEASE 166 0.0055
489 VIRAL INFECTION 182 0.0055
490 HEART RATE INCREASED 537 0.0054
491 PANIC ATTACK 197 0.0054
492 EYE MOVEMENT DISORDER 37 0.0054
493 MUSCLE TIGHTNESS 87 0.0054
494 PHOTOPHOBIA 101 0.0054
495 FAECES SOFT 39 0.0054
496 LEUKOCYTOSIS 97 0.0054
497 PNEUMONIA 1732 0.0053
498 COLITIS ISCHAEMIC 36 0.0053
499 UTERINE LEIOMYOMA 39 0.0053
500 HERNIA 103 0.0053
501 THYROID DISORDER 82 0.0053
502 IRON DEFICIENCY ANAEMIA 49 0.0053
503 INTESTINAL OBSTRUCTION 200 0.0053
504 FATIGUE 4128 0.0053
505 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 377 0.0053
506 FURUNCLE 42 0.0053
507 THROAT IRRITATION 237 0.0053
508 NOCTURIA 64 0.0053
509 PANIC REACTION 38 0.0053
510 RHINORRHOEA 340 0.0053
511 NASAL CONGESTION 309 0.0053
512 ABDOMINAL DISCOMFORT 879 0.0052
513 CHEST PAIN 970 0.0052
514 CANDIDA INFECTION 88 0.0052
515 SMALL INTESTINAL OBSTRUCTION 64 0.0052
516 MYOCLONUS 62 0.0052
517 THERAPY NON-RESPONDER 233 0.0052
518 OEDEMA 281 0.0052
519 NEUTROPHIL COUNT INCREASED 53 0.0052
520 HOT FLUSH 390 0.0052
521 MADAROSIS 60 0.0052
522 ORAL CANDIDIASIS 68 0.0052
523 EAR DISCOMFORT 53 0.0052
524 GAIT DISTURBANCE 984 0.0051
525 DISTURBANCE IN ATTENTION 277 0.0051
526 BLOOD URINE PRESENT 97 0.0051
527 SOMNOLENCE 1022 0.0051
528 GENERAL PHYSICAL HEALTH DETERIORATION 587 0.0051
529 EATING DISORDER 108 0.0051
530 INSOMNIA 1350 0.0051
531 RESPIRATORY DISORDER 151 0.0050
532 PULMONARY THROMBOSIS 55 0.0050
533 FEEDING DISORDER 102 0.0050
534 DRUG TOXICITY 68 0.0050
535 MUSCULOSKELETAL DISORDER 95 0.0050
536 OVERDOSE 1075 0.0050
537 BLOOD MAGNESIUM DECREASED 43 0.0050
538 HEART RATE IRREGULAR 112 0.0050
539 BONE LOSS 74 0.0049
540 HYPOXIA 173 0.0049
541 TACHYCARDIA 436 0.0049
542 PHARYNGEAL SWELLING 48 0.0049
543 SNEEZING 110 0.0049
544 DYSSTASIA 143 0.0049
545 VITREOUS FLOATERS 48 0.0049
546 FRACTURE 92 0.0049
547 CONFUSIONAL STATE 785 0.0049
548 WEIGHT DECREASED 1355 0.0048
549 GOUT 87 0.0048
550 HEPATITIS 124 0.0048
551 RESPIRATORY RATE INCREASED 43 0.0048
552 EYE PAIN 273 0.0048
553 DRY EYE 241 0.0048
554 DYSURIA 177 0.0048
555 MYOSITIS 43 0.0048
556 SECRETION DISCHARGE 60 0.0048
557 TENDON RUPTURE 59 0.0048
558 ULCER 76 0.0048
559 ALOPECIA 938 0.0048
560 NEUROPATHY PERIPHERAL 453 0.0048
561 PRODUCT DOSE OMISSION ISSUE 1400 0.0048
562 HOSPICE CARE 47 0.0048
563 PULMONARY EMBOLISM 452 0.0048
564 DYSPHONIA 278 0.0047
565 APNOEA 37 0.0047
566 COVID-19 828 0.0047
567 IMMUNE SYSTEM DISORDER 62 0.0047
568 THROMBOCYTOPENIA 524 0.0047
569 CATARACT 279 0.0047
570 IMPAIRED WORK ABILITY 100 0.0047
571 MYALGIA 794 0.0047
572 TREMOR 774 0.0047
573 IMPAIRED DRIVING ABILITY 53 0.0047
574 CONGENITAL ANOMALY 36 0.0046
575 DIABETES MELLITUS 354 0.0046
576 MENTAL DISORDER 202 0.0046
577 ERYTHEMA 954 0.0046
578 POLLAKIURIA 192 0.0046
579 MYDRIASIS 59 0.0046
580 TOOTH EXTRACTION 57 0.0046
581 THERAPEUTIC RESPONSE UNEXPECTED 205 0.0046
582 NAUSEA 3610 0.0046
583 GROIN PAIN 40 0.0046
584 GASTROINTESTINAL DISORDER 407 0.0045
585 OROPHARYNGEAL DISCOMFORT 41 0.0045
586 GINGIVAL PAIN 36 0.0045
587 GASTROENTERITIS 66 0.0045
588 ACCIDENT 54 0.0045
589 MUSCLE RIGIDITY 54 0.0045
590 PELVIC PAIN 82 0.0045
591 THERAPEUTIC RESPONSE SHORTENED 149 0.0045
592 ASTHENIA 1689 0.0045
593 VOMITING 2111 0.0045
594 WHITE BLOOD CELL COUNT INCREASED 172 0.0045
595 ABDOMINAL PAIN 1042 0.0045
596 ACUTE RESPIRATORY DISTRESS SYNDROME 79 0.0045
597 INTENTIONAL OVERDOSE 286 0.0045
598 SKIN FISSURES 87 0.0044
599 RENAL IMPAIRMENT 374 0.0044
600 INCONTINENCE 47 0.0044
601 ACTIVITIES OF DAILY LIVING IMPAIRED 88 0.0044
602 SCAR 76 0.0044
603 DIZZINESS POSTURAL 43 0.0044
604 COUGH 1240 0.0044
605 LYMPHADENOPATHY 156 0.0044
606 HERPES ZOSTER 253 0.0044
607 TENDONITIS 68 0.0044
608 CORONARY ARTERY OCCLUSION 60 0.0044
609 RED BLOOD CELL COUNT DECREASED 125 0.0044
610 THIRST 78 0.0044
611 TOOTHACHE 79 0.0044
612 VERTIGO 265 0.0043
613 PYREXIA 1500 0.0043
614 DRY THROAT 44 0.0043
615 DIZZINESS 2156 0.0043
616 EMOTIONAL DISORDER 133 0.0043
617 MUSCLE SPASTICITY 53 0.0043
618 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
619 COORDINATION ABNORMAL 60 0.0043
620 BACTERAEMIA 51 0.0043
621 DEHYDRATION 573 0.0043
622 DECREASED APPETITE 996 0.0043
623 OEDEMA PERIPHERAL 522 0.0043
624 PULMONARY HYPERTENSION 89 0.0043
625 RASH 1862 0.0043
626 LABORATORY TEST ABNORMAL 126 0.0043
627 ILL-DEFINED DISORDER 259 0.0043
628 COMA 203 0.0043
629 GLAUCOMA 82 0.0043
630 HYPOTHERMIA 43 0.0042
631 URTICARIA 710 0.0042
632 COVID-19 PNEUMONIA 50 0.0042
633 FLATULENCE 240 0.0042
634 BLOOD CALCIUM INCREASED 37 0.0042
635 THROMBOSIS 339 0.0042
636 HYPERCALCAEMIA 52 0.0042
637 ABSCESS 67 0.0042
638 CONDITION AGGRAVATED 1275 0.0042
639 INITIAL INSOMNIA 43 0.0042
640 THINKING ABNORMAL 78 0.0042
641 DRUG EFFECT LESS THAN EXPECTED 62 0.0042
642 SPLENOMEGALY 49 0.0042
643 DIARRHOEA 2698 0.0042
644 SUICIDAL IDEATION 382 0.0042
645 FULL BLOOD COUNT DECREASED 84 0.0042
646 SKIN DISCOLOURATION 191 0.0042
647 SUICIDE ATTEMPT 252 0.0042
648 PROCEDURAL PAIN 115 0.0041
649 RENAL DISORDER 193 0.0041
650 THERAPY INTERRUPTED 296 0.0041
651 OESOPHAGITIS 45 0.0041
652 MICTURITION URGENCY 47 0.0041
653 PULMONARY OEDEMA 184 0.0041
654 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 740 0.0041
655 URINARY RETENTION 137 0.0041
656 RECTAL HAEMORRHAGE 175 0.0041
657 DEPRESSED MOOD 215 0.0041
658 DYSARTHRIA 153 0.0041
659 SKIN ULCER 105 0.0041
660 MOVEMENT DISORDER 130 0.0040
661 DYSPNOEA 2291 0.0040
662 LACERATION 38 0.0040
663 SCAB 46 0.0040
664 PHARYNGITIS 50 0.0040
665 PANCREATITIS 213 0.0040
666 HALLUCINATION, AUDITORY 64 0.0040
667 GASTROINTESTINAL PAIN 44 0.0040
668 CHOKING 78 0.0040
669 DRUG INTERACTION 633 0.0040
670 DYSKINESIA 162 0.0040
671 PRODUCT USE IN UNAPPROVED INDICATION 984 0.0040
672 DERMATITIS 83 0.0040
673 FEELING ABNORMAL 949 0.0040
674 MUSCLE ATROPHY 50 0.0039
675 PARANOIA 68 0.0039
676 INTERNAL HAEMORRHAGE 45 0.0039
677 THERAPY CESSATION 202 0.0039
678 HALLUCINATION 296 0.0039
679 HIP FRACTURE 126 0.0039
680 GASTRIC ULCER 74 0.0039
681 ABDOMINAL DISTENSION 405 0.0039
682 PHOTOSENSITIVITY REACTION 64 0.0039
683 LACRIMATION INCREASED 117 0.0039
684 CLOSTRIDIUM DIFFICILE COLITIS 41 0.0039
685 SARS-COV-2 TEST POSITIVE 51 0.0039
686 BURNING SENSATION 270 0.0038
687 INJECTION SITE DISCOLOURATION 48 0.0038
688 HEAD DISCOMFORT 68 0.0038
689 MENTAL IMPAIRMENT 93 0.0038
690 DYSPHAGIA 364 0.0038
691 CHILLS 449 0.0038
692 SLUGGISHNESS 39 0.0038
693 BLOOD SODIUM DECREASED 72 0.0038
694 LIVER DISORDER 169 0.0038
695 THROAT TIGHTNESS 103 0.0038
696 EUPHORIC MOOD 39 0.0038
697 BACTERIAL INFECTION 71 0.0038
698 COLD SWEAT 67 0.0038
699 HAEMATOCRIT DECREASED 75 0.0038
700 POST PROCEDURAL HAEMORRHAGE 44 0.0038
701 SKIN HAEMORRHAGE 56 0.0038
702 EOSINOPHILIA 66 0.0038
703 PALPITATIONS 441 0.0038
704 SKIN DISORDER 125 0.0037
705 SPEECH DISORDER 196 0.0037
706 GINGIVAL BLEEDING 51 0.0037
707 HYPOMAGNESAEMIA 52 0.0037
708 COLITIS 141 0.0037
709 HYPOKALAEMIA 171 0.0037
710 FEELING COLD 103 0.0037
711 RASH PRURITIC 200 0.0037
712 RENAL PAIN 39 0.0037
713 LOSS OF CONSCIOUSNESS 471 0.0037
714 DIABETES MELLITUS INADEQUATE CONTROL 65 0.0037
715 LOCAL SWELLING 64 0.0037
716 WITHDRAWAL SYNDROME 154 0.0037
717 UNEVALUABLE EVENT 277 0.0037
718 MANIA 60 0.0036
719 BLOOD COUNT ABNORMAL 55 0.0036
720 HAEMOPTYSIS 101 0.0036
721 SWOLLEN TONGUE 113 0.0036
722 ACCIDENTAL OVERDOSE 132 0.0036
723 PNEUMOTHORAX 57 0.0036
724 IRRITABILITY 215 0.0036
725 OCULAR DISCOMFORT 40 0.0036
726 EYE DISCHARGE 37 0.0036
727 CHEST DISCOMFORT 364 0.0036
728 ADRENAL INSUFFICIENCY 43 0.0035
729 HEMIPARESIS 60 0.0035
730 VISUAL IMPAIRMENT 437 0.0035
731 OFF LABEL USE 3077 0.0035
732 THERAPEUTIC RESPONSE DECREASED 213 0.0035
733 DERMATITIS ATOPIC 184 0.0035
734 VISION BLURRED 479 0.0035
735 HYPOPHAGIA 89 0.0035
736 MALAISE 1524 0.0035
737 TARDIVE DYSKINESIA 98 0.0035
738 FLUSHING 353 0.0035
739 METABOLIC ACIDOSIS 111 0.0035
740 DIPLOPIA 90 0.0035
741 ANGINA PECTORIS 99 0.0035
742 ANAPHYLACTIC SHOCK 89 0.0034
743 AGITATION 253 0.0034
744 APHASIA 104 0.0034
745 CRYING 125 0.0034
746 TINNITUS 157 0.0034
747 PRODUCT ADMINISTRATION ERROR 69 0.0034
748 MULTIPLE SCLEROSIS 163 0.0034
749 NEEDLE ISSUE 99 0.0034
750 PARAESTHESIA ORAL 49 0.0034
751 BLOOD PRESSURE DECREASED 225 0.0034
752 GASTRIC DISORDER 116 0.0034
753 SEPSIS 377 0.0034
754 INFLUENZA LIKE ILLNESS 278 0.0034
755 MOUTH ULCERATION 71 0.0034
756 DEMENTIA 94 0.0034
757 ELECTROLYTE IMBALANCE 39 0.0034
758 CARDIAC DISORDER 314 0.0034
759 RASH MACULAR 117 0.0033
760 FEAR 90 0.0033
761 EYE DISORDER 110 0.0033
762 PRODUCT QUALITY ISSUE 454 0.0033
763 CONJUNCTIVITIS 62 0.0033
764 ABDOMINAL PAIN LOWER 84 0.0033
765 ADVERSE REACTION 44 0.0033
766 ORAL DISCOMFORT 46 0.0033
767 PLATELET COUNT INCREASED 43 0.0033
768 EPISTAXIS 246 0.0033
769 BLOOD TRIGLYCERIDES INCREASED 58 0.0033
770 VENTRICULAR TACHYCARDIA 54 0.0033
771 LETHARGY 188 0.0033
772 ADVERSE DRUG REACTION 293 0.0033
773 PLASMA CELL MYELOMA 127 0.0033
774 PRURITUS 1249 0.0032
775 EYE IRRITATION 187 0.0032
776 CARDIAC FAILURE CONGESTIVE 260 0.0032
777 MULTIPLE SCLEROSIS RELAPSE 220 0.0032
778 FEELING JITTERY 61 0.0032
779 HAEMOGLOBIN DECREASED 327 0.0032
780 DYSGEUSIA 235 0.0032
781 DELUSION 49 0.0032
782 BASAL CELL CARCINOMA 49 0.0031
783 MALIGNANT MELANOMA 42 0.0031
784 HAEMATOCHEZIA 173 0.0031
785 SWELLING FACE 204 0.0031
786 CLOSTRIDIUM DIFFICILE INFECTION 68 0.0031
787 PRODUCT USE COMPLAINT 49 0.0031
788 WHITE BLOOD CELL COUNT DECREASED 336 0.0031
789 BRADYCARDIA 164 0.0031
790 ATRIAL FIBRILLATION 301 0.0031
791 AGEUSIA 77 0.0031
792 GENERALISED TONIC-CLONIC SEIZURE 51 0.0031
793 MOOD ALTERED 84 0.0031
794 BLOOD POTASSIUM INCREASED 50 0.0031
795 SYNCOPE 308 0.0031
796 NERVOUSNESS 159 0.0030
797 TREATMENT NONCOMPLIANCE 165 0.0030
798 THERAPY PARTIAL RESPONDER 47 0.0030
799 BRAIN OEDEMA 38 0.0030
800 RESPIRATORY DISTRESS 83 0.0030
801 PARALYSIS 43 0.0030
802 COAGULOPATHY 50 0.0030
803 LYMPHOCYTE COUNT DECREASED 53 0.0030
804 DYSTONIA 58 0.0030
805 PANCREATITIS ACUTE 67 0.0030
806 PRODUCT DOSE OMISSION 194 0.0030
807 PULMONARY ARTERIAL HYPERTENSION 43 0.0030
808 ANAEMIA 564 0.0030
809 SHOCK 68 0.0030
810 INJECTION SITE BRUISING 235 0.0029
811 HYPERGLYCAEMIA 107 0.0029
812 TRANSIENT ISCHAEMIC ATTACK 99 0.0029
813 ANGER 99 0.0029
814 UPPER GASTROINTESTINAL HAEMORRHAGE 49 0.0029
815 BLOOD CREATININE INCREASED 190 0.0029
816 SEIZURE 336 0.0029
817 SKIN CANCER 62 0.0029
818 CHROMATURIA 65 0.0029
819 PRESYNCOPE 70 0.0029
820 ARRHYTHMIA 136 0.0029
821 BLOOD UREA INCREASED 48 0.0029
822 METASTASES TO BONE 47 0.0029
823 ABNORMAL DREAMS 79 0.0029
824 HAEMATOMA 74 0.0029
825 RHABDOMYOLYSIS 119 0.0029
826 HYPERKALAEMIA 100 0.0028
827 MYOCARDIAL INFARCTION 497 0.0028
828 HAEMATURIA 97 0.0028
829 LUNG INFECTION 44 0.0028
830 EYE PRURITUS 95 0.0028
831 PLEURAL EFFUSION 172 0.0028
832 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 155 0.0028
833 ANAPHYLACTIC REACTION 156 0.0028
834 PLATELET COUNT DECREASED 299 0.0028
835 HOSPITALISATION 430 0.0028
836 DRUG INEFFECTIVE 3687 0.0028
837 ERUCTATION 54 0.0028
838 FEMUR FRACTURE 86 0.0028
839 DISORIENTATION 110 0.0028
840 INCREASED APPETITE 53 0.0028
841 PRODUCT AVAILABILITY ISSUE 63 0.0028
842 INJECTION SITE PRURITUS 185 0.0028
843 SKIN EXFOLIATION 233 0.0028
844 BLOOD GLUCOSE ABNORMAL 51 0.0028
845 RESPIRATORY FAILURE 201 0.0028
846 NERVOUS SYSTEM DISORDER 86 0.0028
847 INJECTION SITE SWELLING 209 0.0027
848 PERICARDIAL EFFUSION 63 0.0027
849 LIP SWELLING 90 0.0027
850 SEPTIC SHOCK 117 0.0027
851 COMPLICATION ASSOCIATED WITH DEVICE 39 0.0027
852 PNEUMONITIS 73 0.0027
853 INJECTION SITE PAIN 822 0.0027
854 FLUID OVERLOAD 39 0.0027
855 PAIN OF SKIN 72 0.0027
856 HUNGER 37 0.0027
857 HYPOAESTHESIA ORAL 40 0.0027
858 LYMPHOMA 41 0.0027
859 EYE SWELLING 98 0.0026
860 CYANOSIS 41 0.0026
861 MOOD SWINGS 83 0.0026
862 LEUKOPENIA 130 0.0026
863 BLINDNESS 105 0.0026
864 RESTLESSNESS 94 0.0026
865 PNEUMONIA ASPIRATION 64 0.0026
866 DEVICE OCCLUSION 36 0.0026
867 OSTEONECROSIS 84 0.0026
868 GASTROINTESTINAL HAEMORRHAGE 213 0.0025
869 PREGNANCY 51 0.0025
870 PSYCHOTIC DISORDER 75 0.0025
871 DEVICE RELATED INFECTION 39 0.0025
872 HYPONATRAEMIA 142 0.0025
873 INJECTION SITE MASS 93 0.0025
874 EJECTION FRACTION DECREASED 39 0.0025
875 CEREBROVASCULAR ACCIDENT 425 0.0025
876 INJECTION SITE REACTION 172 0.0025
877 SENSORY DISTURBANCE 40 0.0025
878 ANGIOEDEMA 110 0.0025
879 PSYCHOMOTOR HYPERACTIVITY 41 0.0025
880 APATHY 36 0.0025
881 OSTEONECROSIS OF JAW 61 0.0025
882 DRY SKIN 329 0.0025
883 ABNORMAL BEHAVIOUR 97 0.0024
884 FAECES DISCOLOURED 53 0.0024
885 DRUG LEVEL INCREASED 40 0.0024
886 ACUTE MYOCARDIAL INFARCTION 71 0.0024
887 DRUG EFFECT INCOMPLETE 87 0.0024
888 ECZEMA 124 0.0024
889 BLOOD GLUCOSE DECREASED 113 0.0024
890 HYPOACUSIS 101 0.0023
891 INTENTIONAL SELF-INJURY 47 0.0023
892 PRURITUS GENERALISED 50 0.0023
893 ABASIA 57 0.0023
894 ADVERSE EVENT 212 0.0023
895 OCULAR HYPERAEMIA 109 0.0023
896 RASH PAPULAR 51 0.0023
897 DEAFNESS 59 0.0023
898 MUCOSAL INFLAMMATION 59 0.0023
899 FACE OEDEMA 38 0.0023
900 DRUG EFFECT DECREASED 120 0.0022
901 ALTERED STATE OF CONSCIOUSNESS 48 0.0022
902 RENAL FAILURE ACUTE 94 0.0022
903 HYPOGLYCAEMIA 107 0.0022
904 PRODUCT PHYSICAL ISSUE 44 0.0022
905 HALLUCINATION, VISUAL 46 0.0022
906 HAEMATEMESIS 55 0.0022
907 DRUG DOSE OMISSION 358 0.0022
908 COLITIS ULCERATIVE 96 0.0021
909 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 50 0.0021
910 PALLOR 58 0.0021
911 AMENORRHOEA 37 0.0021
912 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 54 0.0021
913 DEVICE ISSUE 188 0.0021
914 INJECTION SITE RASH 64 0.0021
915 HAEMORRHAGE 218 0.0021
916 VAGINAL HAEMORRHAGE 90 0.0021
917 WRONG TECHNIQUE IN DRUG USAGE PROCESS 75 0.0021
918 DRUG WITHDRAWAL SYNDROME 179 0.0020
919 INJECTION SITE URTICARIA 50 0.0020
920 LIVER FUNCTION TEST ABNORMAL 59 0.0020
921 GLYCOSYLATED HAEMOGLOBIN INCREASED 51 0.0020
922 CARDIOVASCULAR DISORDER 51 0.0020
923 DISEASE PROGRESSION 236 0.0020
924 UNDERDOSE 145 0.0020
925 MENORRHAGIA 39 0.0020
926 NEOPLASM PROGRESSION 69 0.0020
927 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 141 0.0020
928 INCORRECT DOSE ADMINISTERED 452 0.0020
929 ACNE 150 0.0020
930 PRODUCT SUBSTITUTION ISSUE 113 0.0020
931 ASPARTATE AMINOTRANSFERASE INCREASED 104 0.0020
932 DIABETIC KETOACIDOSIS 47 0.0020
933 NEOPLASM MALIGNANT 130 0.0019
934 CARDIAC FAILURE 156 0.0019
935 MEDICATION ERROR 108 0.0019
936 BLOOD GLUCOSE INCREASED 365 0.0019
937 PRODUCT PRESCRIBING ERROR 46 0.0019
938 FEBRILE NEUTROPENIA 127 0.0019
939 EXTRAPYRAMIDAL DISORDER 47 0.0019
940 INJECTION SITE ERYTHEMA 234 0.0019
941 DEVICE DISLOCATION 81 0.0019
942 CONVULSION 106 0.0019
943 DEATH 1595 0.0018
944 PRODUCT DISPENSING ERROR 40 0.0018
945 ERECTILE DYSFUNCTION 47 0.0018
946 BLOOD ALKALINE PHOSPHATASE INCREASED 45 0.0018
947 DRUG DEPENDENCE 286 0.0018
948 APPLICATION SITE PAIN 39 0.0018
949 DRUG-INDUCED LIVER INJURY 54 0.0017
950 AGGRESSION 86 0.0017
951 PANCYTOPENIA 96 0.0017
952 PRODUCT PRESCRIBING ISSUE 37 0.0017
953 ALANINE AMINOTRANSFERASE INCREASED 103 0.0017
954 HEPATIC FAILURE 50 0.0017
955 PRODUCT ADHESION ISSUE 59 0.0016
956 INCORRECT DRUG ADMINISTRATION DURATION 46 0.0016
957 ASCITES 48 0.0016
958 VISUAL ACUITY REDUCED 54 0.0016
959 EXPOSURE VIA SKIN CONTACT 42 0.0016
960 LUNG NEOPLASM MALIGNANT 66 0.0016
961 INJECTION SITE HAEMORRHAGE 126 0.0016
962 NEUTROPHIL COUNT DECREASED 63 0.0015
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 313 0.0015
964 FOETAL EXPOSURE DURING PREGNANCY 125 0.0015
965 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
966 DEVICE BREAKAGE 61 0.0015
967 DISEASE RECURRENCE 70 0.0015
968 BLOOD BILIRUBIN INCREASED 39 0.0014
969 INTERNATIONAL NORMALISED RATIO INCREASED 40 0.0014
970 NEUTROPENIA 189 0.0014
971 EXPIRED PRODUCT ADMINISTERED 46 0.0014
972 MULTIPLE ORGAN DYSFUNCTION SYNDROME 39 0.0014
973 DEVICE MALFUNCTION 96 0.0014
974 BREAST CANCER FEMALE 36 0.0013
975 ACCIDENTAL EXPOSURE TO PRODUCT 126 0.0012
976 EXTRA DOSE ADMINISTERED 49 0.0012
977 CEREBRAL HAEMORRHAGE 42 0.0012
978 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 39 0.0012
979 MALIGNANT NEOPLASM PROGRESSION 117 0.0011
980 SKIN IRRITATION 52 0.0011
981 ELECTROCARDIOGRAM QT PROLONGED 40 0.0011
982 SKIN BURNING SENSATION 78 0.0011
983 NO ADVERSE EVENT 189 0.0010
984 DEVICE LEAKAGE 42 0.0010
985 PRODUCT STORAGE ERROR 77 0.0009
986 INTERSTITIAL LUNG DISEASE 42 0.0009
987 BREAST CANCER 79 0.0008
988 DEPENDENCE 44 0.0008
989 DEVICE DIFFICULT TO USE 36 0.0005
990 PROSTATE CANCER 39 0.0005
991 DRUG DOSE OMISSION BY DEVICE 37 0.0005